Finance

Lists
532989:BOM
Bafna Pharmaceuticals Ltd
459,50 INR
+1,90%
(+8,55) 1D
15 ოქტ, 15:30:00 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for 532989...
Open
459,95 INR
High
459,95 INR
Low
459,50 INR
Mkt. cap
10,69 მლრდ.
Avg. vol.
4,55 ათ.
Volume
2,51 ათ.
P/E ratio
141,94
52-wk high
459,95 INR
52-wk low
95,00 INR
EPS
3,24 INR
No. of employees
339
Open
459,95 INR
High
459,95 INR
Low
459,50 INR
Mkt. cap
10,69 მლრდ.
Avg. vol.
4,55 ათ.
Volume
2,51 ათ.
P/E ratio
141,94
52-wk high
459,95 INR
52-wk low
95,00 INR
EPS
3,24 INR
No. of employees
339
News stories
From web sources and news partners
About Bafna Pharmaceuticals Ltd
CEO-
Employees339
Founded1981
Headquarters-
SectorPharmaceutical industry
Websitebafnapharma.com
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
354,68 მლნ.
382,86 მლნ.
422,39 მლნ.
265,83 მლნ.
Cost of goods sold
230,62 მლნ.
272,68 მლნ.
300,04 მლნ.
174,98 მლნ.
Cost of revenue
230,62 მლნ.
272,68 მლნ.
300,04 მლნ.
174,98 მლნ.
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
54,90 მლნ.
53,45 მლნ.
70,76 მლნ.
56,16 მლნ.
Operating expense
95,97 მლნ.
95,38 მლნ.
96,58 მლნ.
99,84 მლნ.
Total operating expenses
326,59 მლნ.
368,06 მლნ.
396,62 მლნ.
274,82 მლნ.
Operating income
28,10 მლნ.
14,80 მლნ.
25,77 მლნ.
-8,99 მლნ.
Other non operating income
11,80 მლნ.
12,19 მლნ.
-28,65 მლნ.
19,11 მლნ.
EBT including unusual items
31,25 მლნ.
18,37 მლნ.
26,20 მლნ.
751,00 ათ.
EBT excluding unusual items
31,25 მლნ.
18,37 მლნ.
26,19 მლნ.
751,00 ათ.
Income tax expense
-
-
-1,30 მლნ.
-
Effective tax rate
-
-
-4,95%
-
Other operating expenses
26,34 მლნ.
26,23 მლნ.
9,22 მლნ.
25,87 მლნ.
Net income
31,25 მლნ.
18,37 მლნ.
27,49 მლნ.
751,00 ათ.
Net profit margin
8,81%
4,80%
6,51%
0,28%
Earnings per share
-
-
-
-
Interest and investment income
-
-
679,00 ათ.
-
Interest expense
-8,64 მლნ.
-8,62 მლნ.
-8,68 მლნ.
-9,37 მლნ.
Net interest expenses
-8,64 მლნ.
-8,62 მლნ.
-8,00 მლნ.
-9,37 მლნ.
Depreciation and amortization charges
14,73 მლნ.
15,70 მლნ.
16,60 მლნ.
17,81 მლნ.
EBITDA
42,31 მლნ.
27,02 მლნ.
40,95 მლნ.
6,19 მლნ.
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google აპები